|
Trial no.:
|
PACTR201701001868213 |
Date of Registration:
|
14/11/2016 |
|
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
| TRIAL DESCRIPTION |
|
Public title
|
Comparing 2 medications in management of necrotic pulp in primary molars |
| Official scientific title |
Evaluation of Postoperative Pain after Using 3MIX-TATIN Versus Calcium Hydroxide Iodoform Paste In Necrotic Primary Molars Treated by Lesion Sterilization and Tissue Repair Therapy: A Randomized Controlled Trial |
|
Brief summary describing the background
and objectives of the trial
|
to compare 2 medications in treating necrotic primary molars in children one is gold standard and called calcium hydroxid iodofrom paste and the comarator is in innovative called 3-mixtatin , the objective is to treat hopless primary molars by the newly introduced material |
| Type of trial |
RCT |
| Acronym (If the trial has an acronym then please provide) |
|
| Disease(s) or condition(s) being studied |
necrotic primary molars |
| Sub-Disease(s) or condition(s) being studied |
|
| Purpose of the trial |
Treatment: Drugs |
| Anticipated trial start date |
30/11/2016 |
| Actual trial start date |
01/12/2016 |
| Anticipated date of last follow up |
01/08/2017 |
| Actual Last follow-up date |
01/09/2016 |
| Anticipated target sample size (number of participants) |
92 |
| Actual target sample size (number of participants) |
92 |
| Recruitment status |
Not yet recruiting |
| Publication URL |
|
|